Neurogen Biomarking
Supports early detection of Alzheimer’s disease and Mild Cognitive Impairment by offering tools, education, and motivation for anyone with thinking and memory concerns to access advanced, personalized care.
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A